1. Home
  2. CLSD vs PSQH Comparison

CLSD vs PSQH Comparison

Compare CLSD & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • PSQH
  • Stock Information
  • Founded
  • CLSD 2011
  • PSQH 2021
  • Country
  • CLSD United States
  • PSQH United States
  • Employees
  • CLSD N/A
  • PSQH N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • PSQH Advertising
  • Sector
  • CLSD Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • CLSD 74.3M
  • PSQH 75.3M
  • IPO Year
  • CLSD 2016
  • PSQH N/A
  • Fundamental
  • Price
  • CLSD $0.93
  • PSQH $4.64
  • Analyst Decision
  • CLSD Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • CLSD 6
  • PSQH 2
  • Target Price
  • CLSD $5.33
  • PSQH $5.75
  • AVG Volume (30 Days)
  • CLSD 301.0K
  • PSQH 1.8M
  • Earning Date
  • CLSD 03-11-2025
  • PSQH 03-13-2025
  • Dividend Yield
  • CLSD N/A
  • PSQH N/A
  • EPS Growth
  • CLSD N/A
  • PSQH N/A
  • EPS
  • CLSD N/A
  • PSQH N/A
  • Revenue
  • CLSD $7,703,000.00
  • PSQH $18,738,575.00
  • Revenue This Year
  • CLSD N/A
  • PSQH $320.53
  • Revenue Next Year
  • CLSD $91.87
  • PSQH $56.41
  • P/E Ratio
  • CLSD N/A
  • PSQH N/A
  • Revenue Growth
  • CLSD 248.39
  • PSQH 482.62
  • 52 Week Low
  • CLSD $0.80
  • PSQH $2.00
  • 52 Week High
  • CLSD $2.12
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 42.76
  • PSQH 57.59
  • Support Level
  • CLSD $0.90
  • PSQH $3.58
  • Resistance Level
  • CLSD $0.97
  • PSQH $4.90
  • Average True Range (ATR)
  • CLSD 0.05
  • PSQH 0.50
  • MACD
  • CLSD 0.00
  • PSQH -0.03
  • Stochastic Oscillator
  • CLSD 24.29
  • PSQH 66.25

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. The primary mission of the platform is to help consumers "shop their values" and put purpose behind purchases. It has two reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes.

Share on Social Networks: